What this study is
The overall goal of this project is to determine if measuring blood pressure at home and staying in contact with a team of pharmacists and physicians to manage participants' blood pressure is useful. The study will enroll 400 participants who are seen at the University of Alabama at Birmingham Emergency Department - Transitional Care Clinic and Tampa General Hospital -Transitional Care Clinic. Half of the participants (200 patients) will be asked to measure blood pressure at home, and half of the participants (200 patients) will continue to receive usual care. Participants who measure blood pressure at home will also meet with a pharmacist weekly over the phone to discuss blood pressure readings and have blood pressure medications prescribed if needed. This program will last 6 months.
What's being tested
- Remote Blood Pressure Monitoring + Telehealth
Intervention · BEHAVIORAL
Participants will undergo remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management
Study details
- Official title
- REmote Blood Pressure Monitoring and Pharmacist-Led Telehealth Program in an Emergency Department Transitional Care Clinic
- Sponsor
- University of Alabama at Birmingham
- Conditions
- Hypertension · Blood Pressure
- Enrolling
- 420 people
- Starts
- 2027-04-01
- Est. completion
- 2031-01
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Age ≥18 years
- Ability to speak English
- Seen at UAB's or TGH's Emergency Department-Transitional Care Clinic
- Blood pressure at Emergency Department-Transitional Care Clinic: Systolic BP ≥ 130 mmHg or Diastolic BP ≥ 80 mmHg
- Have a cellphone with video capability
You can't join if
- Systolic BP ≥ 160 mmHg or Diastolic BP ≥ 100 mmHg (i.e. severe range hypertension (HTN) by the 2025 American College of Cardiology/American Heart Association BP guidelines) as they typically are referred to immediate treatment intensification. Since the prevalence of severe HTN is low (i.e.<5%) in the US population, exclusion of these individuals will have only a small effect on the study.)
- Lack of willingness or inability to provide written informed consent
- Individuals who work overnight or second shift
- History of known major arrhythmias
- Currently pregnant or breastfeeding
- Arm circumference >50 cm. *The upper limit for the largest BP cuff for oscillometric BP devices is typically 50-52 cm; data from the National Health and Nutrition Examination Survey, 2011-2016 indicated that <1% of US adults have an arm circumference >50 cm, so this will have minimal effect on our study.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openUniversity of Alabama at Birmingham
Birmingham, Alabama, United States
- Tammi Thomas · Contact205-934-7839tammithomas@uabmc.edu
- Bernadette Johnson · Contact205-934-7329bajohnson@uabmc.edu
Study team
Sponsor
University of Alabama at Birmingham
Study ID IRB-300016615
Principal investigator
Lama Ghazi, MD, PhD
University of Alabama at Birmingham
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.